Back to search

Article

Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity

2021-04-06

Abstract excerpt

SARS-CoV-2 is the novel coronavirus that is the causative agent of COVID-19, a sometimes-lethal respiratory infection responsible for a world-wide pandemic. The envelope (E) protein, one of four structural proteins encoded in the viral genome, is a 75-residue integral membrane protein whose transmembrane domain exhibits ion channel activity and whose cytoplasmic domain participates in protein-protein interactions....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f867ab8-939d-5b4a-8555-10f44c7cfa12
DOI
10.1101/2021.04.06.438579
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activityDOI 10.1101/2021.04.06.438579
Select a neighboring publication to make it the new centre.